TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
MIR23B |
|
microRNA 23b
|
|
|
0.523 |
0.808 |
MIR224 |
|
microRNA 224
|
|
|
0.534 |
0.654 |
KIR2DS1 |
Q14954
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 1
|
Receptor
|
|
0.537 |
0.769 |
H4C15 |
P62805
|
H4 clustered histone 15
|
|
|
0.541 |
0.692 |
H4C14 |
P62805
|
H4 clustered histone 14
|
|
|
0.541 |
0.692 |
THAS |
|
thoracoabdominal syndrome
|
|
|
0.560 |
0.808 |
IFN1@ |
|
interferon, type 1, cluster
|
|
|
0.565 |
0.731 |
CDR1 |
P51861
|
cerebellar degeneration related protein 1
|
|
|
0.576 |
0.808 |
MIR663A |
|
microRNA 663a
|
|
|
0.576 |
0.769 |
FCGR2C |
P31995
|
Fc fragment of IgG receptor IIc (gene/pseudogene)
|
Cell adhesion
|
|
0.610 |
0.654 |
WG |
|
Wegener granulomatosis
|
|
|
0.595 |
0.808 |
HRES1 |
P13985
|
HTLV-1 related endogenous sequence
|
|
|
0.636 |
0.615 |
H3C9P |
|
H3 clustered histone 9, pseudogene
|
|
|
0.656 |
0.538 |
LOC102723971 |
|
lipocalin 1-like
|
|
|
0.663 |
0.577 |
ERVW-4 |
|
endogenous retrovirus group W member 4
|
|
|
0.686 |
0.615 |
HLA-H |
P01893
|
major histocompatibility complex, class I, H (pseudogene)
|
|
|
0.736 |
0.500 |
MIR633 |
|
microRNA 633
|
|
|
0.769 |
0.346 |
LBX1-AS1 |
|
LBX1 antisense RNA 1
|
|
|
0.792 |
0.231 |
IFNR |
|
interferon production regulator
|
|
|
0.792 |
0.192 |
H3C15 |
Q71DI3
|
H3 clustered histone 15
|
|
|
0.821 |
0.231 |
H3C14 |
Q71DI3
|
H3 clustered histone 14
|
|
|
0.861 |
0.154 |
SLEB4 |
|
systemic lupus erythematosus, susceptibility to, 4
|
|
|
0.861 |
0.154 |
RFH1 |
|
Renal failure, progressive, with hypertension
|
|
|
0.861 |
0.154 |